Tag: vaccine

Vaxxas, a clinical-stage biotechnology company known for its innovative high-density microarray patch (HD-MAP) vaccination platform, has secured a worldwide license from the United States National Institutes of Health (NIH) for a next-generation vaccine antigen aimed at combating Respiratory Syncytial Virus (RSV). 

Researchers from the Centenary Institute and the University of Sydney have made a breakthrough in vaccine science by uncovering new insights into delta inulin, a crucial vaccine component.

The NSW Government announced it is investing in and prioritising the biosecurity of NSW, with a cutting-edge emergency animal disease vaccine reaching a major milestone.

La Trobe University’s Melbourne campus will soon become home to a new BioNTech facility that will manufacture new investigational mRNA therapies for serious diseases like cancer. 

Researchers from the University of Adelaide have received federal grants that will support two projects that will help develop a vaccine to protect poultry against salmonella and identify important plant compounds. 

A team of scientific experts are developing a biopolymer particle-based platform technology that will bring Australia a step closer towards establishing a sovereign capability to rapidly manufacture vaccines against emerging infectious diseases. 

Biotechnology company Vaxxas has completed work on its new needle-free vaccine technology manufacturing facility in Northshore Hamilton. 

Australia biotechnology company Vaxxas said it achieved positive interim results from a Phase I human clinical trial with the first needle-free COVID-19 vaccine candidate. 

CSL Seqirus has reached a major milestone in the construction of its new cutting-edge manufacturing facility for vaccine and antivenom manufacturing. 

Walter and Eliza Hall of Medical Research (WEHI) has received a $900,000 grant from the Medical Research Future Fund for a research study that could produce a vaccine for patients with hard-to-treat cancers.